Skip to main content

Articles

Page 36 of 60

  1. The coronary risk in diabetes (CoRDia) trial (n = 211) compares the effectiveness of usual diabetes care with a self-management intervention (SMI), with and without personalised risk information (including gen...

    Authors: Katherine E. Beaney, Claire E. Ward, Dauda A. S. Bappa, Nadine McGale, Anna K. Davies, Shashivadan P. Hirani, KaWah Li, Philip Howard, Dwaine R. Vance, Martin A. Crockard, John V. Lamont, Stanton Newman and Steve E. Humphries
    Citation: Cardiovascular Diabetology 2016 15:141
    Content type: Original investigation Published on:

  2. Type 2 diabetes mellitus (T2DM) is a recognized trigger factor for heart failure with preserved ejection fraction (HFpEF). Recent studies show that higher serum calcium level is associated with greater risk of...

    Authors: Junfeng Li, Nan Wu, Wenling Dai, Liu Jiang, Yintao Li, Shibao Li and Zhongyuan Wen
    Citation: Cardiovascular Diabetology 2016 15:140
    Content type: Original investigation Published on:

  3. Cardiovascular disease (CVD) is one of the most common diabetes-associated complications, as well as a leading cause for death in type 2 diabetes patients (T2D). Despite the well-known correlation between the ...

    Authors: Oliver Schnell, Lars Rydén, Eberhard Standl and Antonio Ceriello
    Citation: Cardiovascular Diabetology 2016 15:139
    Content type: Review Published on:

  4. In patients with type 2 diabetes (T2D), responsiveness of serum lipid concentrations to dietary patterns may vary by genotype. The aims of the present study were to identify explorative dietary patterns and to...

    Authors: Katharina S. Weber, Birgit Knebel, Klaus Strassburger, Jörg Kotzka, Peter Stehle, Julia Szendroedi, Karsten Müssig, Anette E. Buyken and Michael Roden
    Citation: Cardiovascular Diabetology 2016 15:138
    Content type: Original investigation Published on:

  5. Recently, genetic studies have suggested a causal relationship between cholesterol remnants and ischemic heart disease. We aimed to determine whether cholesterol remnants and its marker, triglyceride levels, a...

    Authors: Peter Godsk Jørgensen, Magnus Thorsten Jensen, Tor Biering-Sørensen, Rasmus Mogelvang, Søren Galatius, Thomas Fritz-Hansen, Peter Rossing, Tina Vilsbøll and Jan Skov Jensen
    Citation: Cardiovascular Diabetology 2016 15:137
    Content type: Original investigation Published on:

  6. Left ventricular (LV) dysfunction is closely associated with LV hypertrophy or diabetes, as well as insufficient autophagic flux. Acute or chronic hyperglycemia is a prognostic factor for patients with myocard...

    Authors: Jiahe Xie, Kai Cui, Huixin Hao, Yingxue Zhang, Hairuo Lin, Zhenhuan Chen, Xiaobo Huang, Shiping Cao, Wangjun Liao, Jianping Bin, Masafumi Kitakaze and Yulin Liao
    Citation: Cardiovascular Diabetology 2016 15:136
    Content type: Original investigation Published on:

  7. While most studies focus on cardiovascular morbidity following anesthesia and surgery in excessive obesity, it is unknown whether these intraoperative cardiovascular alterations also occur in milder forms of a...

    Authors: Chantal A. Boly, Etto C. Eringa, R. Arthur Bouwman, Rob F. P. van den Akker, Frances S. de Man, Ingrid Schalij, Stephan A. Loer, Christa Boer and Charissa E. van den Brom
    Citation: Cardiovascular Diabetology 2016 15:135
    Content type: Original investigation Published on:

  8. As a sub-analysis of the PROLOGUE study, we evaluated the long-term effect of sitagliptin, a dipeptidyl peptidase 4 inhibitor, on endothelial function in the conduit brachial artery in patients with type 2 dia...

    Authors: Tatsuya Maruhashi, Yukihito Higashi, Yasuki Kihara, Hirotsugu Yamada, Masataka Sata, Shinichiro Ueda, Masato Odawara, Yasuo Terauchi, Kazuoki Dai, Jun Ohno, Masato Iida, Hiroaki Sano, Hirofumi Tomiyama, Teruo Inoue, Atsushi Tanaka, Toyoaki Murohara…
    Citation: Cardiovascular Diabetology 2016 15:134
    Content type: Original investigation Published on:

  9. Type 2 diabetes mellitus is associated strongly with an increased risk of micro- and macro-vascular complications, leading to impaired quality of life and shortened life expectancy. In addition to appropriate ...

    Authors: Atsushi Tanaka, Toyoaki Murohara, Isao Taguchi, Kazuo Eguchi, Makoto Suzuki, Masafumi Kitakaze, Yasunori Sato, Tomoko Ishizu, Yukihito Higashi, Hirotsugu Yamada, Mamoru Nanasato, Michio Shimabukuro, Hiroki Teragawa, Shinichiro Ueda, Satoshi Kodera, Munehide Matsuhisa…
    Citation: Cardiovascular Diabetology 2016 15:133
    Content type: Study protocol Published on:

  10. Angiopoietin-like protein 3 (ANGPTL3) is a major lipoprotein regulator and shows positive correlation with high-density lipoprotein-cholesterol (HDL-c) in population studies and ANGPTL3 mutated subjects. Howev...

    Authors: Dong Zhao, Long-Yan Yang, Xu-Hong Wang, Sha-Sha Yuan, Cai-Guo Yu, Zong-Wei Wang, Jia-Nan Lang and Ying-Mei Feng
    Citation: Cardiovascular Diabetology 2016 15:132
    Content type: Original investigation Published on:

  11. We aimed to investigate the mortality rate (MR), causes of death and standardized mortality ratio (SMR) in Korean type 2 diabetic patients from 2002 to 2013 using data from the Korean National Health Insurance...

    Authors: Yu Mi Kang, Ye-Jee Kim, Joong-Yeol Park, Woo Je Lee and Chang Hee Jung
    Citation: Cardiovascular Diabetology 2016 15:131
    Content type: Original investigation Published on:

  12. An emerging treatment modality for reducing damage caused by ischaemia–reperfusion injury is ischaemic conditioning. This technique induces short periods of ischaemia that have been found to protect against a ...

    Authors: J. A. Epps and N. A. Smart
    Citation: Cardiovascular Diabetology 2016 15:130
    Content type: Review Published on:

  13. Peripheral arterial disease (PAD) is known to be associated with high cardiovascular risk, but the individual impact of PAD presentations on risk of macrovascular and microvascular events has not been reliably...

    Authors: Kamel Mohammedi, Mark Woodward, Yoichiro Hirakawa, Sophia Zoungas, Stephen Colagiuri, Pavel Hamet, Stephen Harrap, Neil Poulter, David R. Matthews, Michel Marre and John Chalmers
    Citation: Cardiovascular Diabetology 2016 15:129
    Content type: Original investigation Published on:

  14. Vitamin D status has been hypothesized to protect against development of diabetic retinopathy via its anti-inflammatory and anti-angiogenic properties. Additionally, in vitro and in vivo studies suggest vitami...

    Authors: Amy E. Millen, Michelle W. Sahli, Jing Nie, Michael J. LaMonte, Pamela L. Lutsey, Barbara E. K. Klein, Julie A. Mares, Kirstin J. Meyers, Christopher A. Andrews and Ronald Klein
    Citation: Cardiovascular Diabetology 2016 15:128
    Content type: Original investigation Published on:

  15. We aimed to analyze the relationships between skin autofluorescence (SAF) and incident macrovascular events and renal impairment after 4 years of follow-up in patients with type 1 diabetes (T1D).

    Authors: Fritz-Line Vélayoudom-Céphise, Kalina Rajaobelina, Catherine Helmer, Sovanndany Nov, Emilie Pupier, Laurence Blanco, Marie Hugo, Blandine Farges, Cyril Astrugue, Henri Gin and Vincent Rigalleau
    Citation: Cardiovascular Diabetology 2016 15:127
    Content type: Original investigation Published on:

  16. Although increased oxidative stress is a major component of diabetic hypertensive cardiomyopathy, research into the effects of antioxidants on cardiac remodeling remains scarce. The actions of antioxidant apoc...

    Authors: C. M. Rosa, R. Gimenes, D. H. S. Campos, G. N. Guirado, C. Gimenes, A. A. H. Fernandes, A. C. Cicogna, R. M. Queiroz, I. Falcão-Pires, D. Miranda-Silva, P. Rodrigues, F. R. Laurindo, D. C. Fernandes, C. R. Correa, M. P. Okoshi and K. Okoshi
    Citation: Cardiovascular Diabetology 2016 15:126
    Content type: Original investigation Published on:

  17. Pleiotropic effects on cardiovascular protection have been suggested in several oral antidiabetic drugs (OAD). The impacts of OADs on aortic aneurysm (AA) growth have been found in animal studies, but the evid...

    Authors: Chien-Yi Hsu, Yu-Wen Su, Yung-Tai Chen, Shih-Hung Tsai, Chun-Chin Chang, Szu-Yuan Li, Po-Hsun Huang, Jaw-Wen Chen and Shing-Jong Lin
    Citation: Cardiovascular Diabetology 2016 15:125
    Content type: Original investigation Published on:

  18. Improved outcomes in patients with diabetes mellitus undergoing percutaneous coronary intervention remain an unmet clinical need. We assessed the long-term efficacy and safety of novel polymer-free sirolimus- ...

    Authors: Yukinori Harada, Roisin Colleran, Sebastian Kufner, Daniele Giacoppo, Tobias Rheude, Jonathan Michel, Salvatore Cassese, Tareq Ibrahim, Karl-Ludwig Laugwitz, Adnan Kastrati and Robert A. Byrne
    Citation: Cardiovascular Diabetology 2016 15:124
    Content type: Original investigation Published on:

  19. Increased levels of glucagon in type 2 diabetes are well known and, until now, have been considered deleterious. However, glucagon has an important role in the maintenance of both heart and kidney function. Mo...

    Authors: Antonio Ceriello, Stefano Genovese, Edoardo Mannucci and Edoardo Gronda
    Citation: Cardiovascular Diabetology 2016 15:123
    Content type: Review Published on:

  20. Acid–base imbalance has been reported to increase incidence of hypertension and diabetes. However, the association between diet-induced acid load and cardiovascular disease (CVD) risk in the general population...

    Authors: Eugene Han, Gyuri Kim, Namki Hong, Yong-ho Lee, Dong Woo Kim, Hyun Joon Shin, Byung-Wan Lee, Eun Seok Kang, In-Kyu Lee and Bong-Soo Cha
    Citation: Cardiovascular Diabetology 2016 15:122
    Content type: Original investigation Published on:

  21. Recent experimental studies have revealed that n-3 fatty acids, such as eicosapentaenoic acid (EPA) regulate postprandial insulin secretion, and correct postprandial glucose and lipid abnormalities. However, t...

    Authors: Takahiro Sawada, Hideo Tsubata, Naoko Hashimoto, Michinori Takabe, Taishi Miyata, Kosuke Aoki, Soichiro Yamashita, Shogo Oishi, Tsuyoshi Osue, Kiminobu Yokoi, Yasue Tsukishiro, Tetsuari Onishi, Akira Shimane, Yasuyo Taniguchi, Yoshinori Yasaka, Takeshi Ohara…
    Citation: Cardiovascular Diabetology 2016 15:121
    Content type: Original Investigation Published on:

  22. The metabolic syndrome is becoming increasingly prevalent in the general population that is at simultaneous risk for both type 2 diabetes and cardiovascular disease. The critical pathogenic mechanisms underlyi...

    Authors: V. Moreno-Viedma, M. Amor, A. Sarabi, M. Bilban, G. Staffler, M. Zeyda and T. M. Stulnig
    Citation: Cardiovascular Diabetology 2016 15:120
    Content type: Original investigation Published on:

  23. Type 1 diabetes is associated with increased cardiovascular disease (CVD). Decreased endothelial progenitor cells (EPCs) number plays a pivotal role in reduced endothelial repair and development of CVD. We aim...

    Authors: Fahad W. Ahmed, Rachel Rider, Michael Glanville, Kilimangalam Narayanan, Salman Razvi and Jolanta U. Weaver
    Citation: Cardiovascular Diabetology 2016 15:116
    Content type: Original investigation Published on:

  24. High fat diet (HFD) induces insulin resistance in various tissues, including the vasculature. HFD also increases plasma levels of TNF-α, a cytokine that contributes to insulin resistance and vascular dysfuncti...

    Authors: Rafael Menezes da Costa, Karla Bianca Neves, Fabíola Leslie Mestriner, Paulo Louzada-Junior, Thiago Bruder-Nascimento and Rita C. Tostes
    Citation: Cardiovascular Diabetology 2016 15:119
    Content type: Original investigation Published on:

  25. We intended to analyse the associations between blood glucose (BG) level and clinical outcomes of in-hospital cardiac arrest (IHCA).

    Authors: Chih-Hung Wang, Chien-Hua Huang, Wei-Tien Chang, Min-Shan Tsai, Ping-Hsun Yu, Yen-Wen Wu and Wen-Jone Chen
    Citation: Cardiovascular Diabetology 2016 15:118
    Content type: Original investigation Published on:

  26. Chemokines are critical components in pathology. The roles of chemokine CC motif ligand 4 (CCL4) and its receptor are associated with diabetes mellitus (DM) and atherosclerosis cardiovascular diseases. However...

    Authors: Ting-Ting Chang and Jaw-Wen Chen
    Citation: Cardiovascular Diabetology 2016 15:117
    Content type: Review Published on:

  27. An intergenic locus on chromosome 1 (lead SNP rs10911021) was previously associated with coronary heart disease (CHD) in type 2 diabetes (T2D). Using data from the UCLEB consortium we investigated the relation...

    Authors: Katherine E. Beaney, Jackie A. Cooper, Stela McLachlan, S. Goya Wannamethee, Barbara J. Jefferis, Peter Whincup, Yoav Ben-Shlomo, Jacqueline F. Price, Meena Kumari, Andrew Wong, Ken Ong, Rebecca Hardy, Diana Kuh, Mika Kivimaki, Antti J. Kangas, Pasi Soininen…
    Citation: Cardiovascular Diabetology 2016 15:115
    Content type: Original investigation Published on:

  28. Chronic stress is associated with increased risk of glucose intolerance and cardiovascular diseases, albeit through undefined mechanisms. With the aim of gaining insights into the latter, this study examined t...

    Authors: Vitor H. Pereira, Fernanda Marques, Vânia Lages, Filipa G. Pereira, Alexandre Patchev, Osborne F. X. Almeida, Joana Almeida-Palha, Nuno Sousa and João J. Cerqueira
    Citation: Cardiovascular Diabetology 2016 15:114
    Content type: Original investigation Published on:

  29. Despite the known risk of diabetes-induced cardiac fibrosis, less is known about whether diabetes causes an altered cardiac phenotype independent of coronary atherosclerosis. Peroxisome proliferator-activated ...

    Authors: Wei-Ting Chang, Juei-Tang Cheng and Zhih-Cherng Chen
    Citation: Cardiovascular Diabetology 2016 15:113
    Content type: Original investigation Published on:

  30. There are conflicting results for relationships between serum vitamin D levels and metabolic diseases. The aim of this study was to investigate whether serum vitamin D levels were associated with various metab...

    Authors: Ki-Chul Sung, Yoosoo Chang, Seungho Ryu and Hye-Kyung Chung
    Citation: Cardiovascular Diabetology 2016 15:112
    Content type: Original investigation Published on:

  31. Diabetic patients suffer from a high rate of cardiovascular events and such risk increases with HbA1c. However, lowering HbA1c does not appear to yield the same benefit on macrovascular endpoints, as observed ...

    Authors: Angelo Avogaro, Gian Paolo Fadini, Giorgio Sesti, Enzo Bonora and Stefano Del Prato
    Citation: Cardiovascular Diabetology 2016 15:111
    Content type: Review Published on:

  32. There is a spectacular rise in the global prevalence of type 2 diabetes mellitus (T2DM) due to the worldwide obesity epidemic. However, a significant proportion of T2DM patients are non-obese and they also hav...

    Authors: Márta Sárközy, Gergő Szűcs, Veronika Fekete, Márton Pipicz, Katalin Éder, Renáta Gáspár, Andrea Sója, Judit Pipis, Péter Ferdinandy, Csaba Csonka and Tamás Csont
    Citation: Cardiovascular Diabetology 2016 15:110
    Content type: Original investigation Published on:

  33. Complications of diabetes mellitus (DM) are related not only to elevated plasma glucose, but also plasma glucose fluctuations. However, the specific mechanism underlying the role of plasma glucose fluctuation ...

    Authors: Na Wu, Haitao Shen, Henan Liu, Yanjun Wang, Yu Bai and Ping Han
    Citation: Cardiovascular Diabetology 2016 15:109
    Content type: Original investigation Published on:

  34. This study investigated the association between serum gamma-glutamyltransferase (GGT) level and subclinical atherosclerosis in patients with type 2 diabetes.

    Authors: Hye Eun Yoon, Eun Young Mo, Seok Joon Shin, Sung Dae Moon, Je Ho Han and Eun Sook Kim
    Citation: Cardiovascular Diabetology 2016 15:108
    Content type: Original investigation Published on:

  35. PCSK9 inhibition is a new powerful cholesterol-lowering strategy. Recently, it was reported that CETP inhibitors influence PCSK9 levels as an off-target effect. We explored the relationship between circulating...

    Authors: Josefa Girona, Daiana Ibarretxe, Nuria Plana, Sandra Guaita-Esteruelas, Nuria Amigo, Mercedes Heras and Luis Masana
    Citation: Cardiovascular Diabetology 2016 15:107
    Content type: Original investigation Published on:

  36. We try to analyse the effect of renal functions on death in CAD patients with different body compositions.

    Authors: Yong Peng, Hua Wang, Fei Chen, Fang-yang Huang, Tian-li Xia, Yan-biao Liao, Hua Chai, Peng-ju Wang, Zhi-liang Zuo, Wei Liu, Chen Zhang, Yi-jian Li, Yi-yue Gui, Mao Chen and De-jia Huang
    Citation: Cardiovascular Diabetology 2016 15:106
    Content type: Original investigation Published on:

  37. Patients with type 2 diabetes (T2D) and coronary artery disease (CAD) have increased risk of cardiac dysfunction. The diabetic heart is characterized by increased fatty acid oxidation and reduced glucose uptak...

    Authors: Preman Kumarathurai, Christian Anholm, Olav W. Nielsen, Ole P. Kristiansen, Jens Mølvig, Sten Madsbad, Steen B. Haugaard and Ahmad Sajadieh
    Citation: Cardiovascular Diabetology 2016 15:105
    Content type: Original investigation Published on:

  38. To investigate whether atherogenic dyslipidemia, a dyslipidemic profile combining elevated triglycerides and low high-density lipoprotein (HDL) cholesterol, is predictive of risk of silent myocardial ischemia ...

    Authors: Paul Valensi, Antoine Avignon, Ariane Sultan, Bernard Chanu, Minh Tuan Nguyen and Emmanuel Cosson
    Citation: Cardiovascular Diabetology 2016 15:104
    Content type: Original investigation Published on:

  39. Authors: Ana Lopez-de-Andrés, Isabel Jiménez-Trujillo, Rodrigo Jiménez-García, Valentín Hernández-Barrera, José Mª de Miguel-Yanes, Manuel Méndez-Bailón, Napoleón Perez-Farinos, Miguel Ángel Salinero-Fort and Pilar Carrasco-Garrido
    Citation: Cardiovascular Diabetology 2016 15:103
    Content type: Erratum Published on:

    The original article was published in Cardiovascular Diabetology 2015 14:48

  40. The prevalence of type 2 diabetes (T2DM) in younger adults is growing. Compared to the late onset T2DM, it is well recognized that the disease tends to behave more aggressively in the younger age group with ev...

    Authors: Z. Z. Htike, T. Yates, E. M. Brady, D. Webb, L. J. Gray, D. Swarbrick, G. P. McCann, K. Khunti and M. J. Davies
    Citation: Cardiovascular Diabetology 2016 15:102
    Content type: Study protocol Published on:

  41. Strict glycaemic control in patients with type 2 diabetes has proven to have microvascular benefits while the effects on CVD and mortality are less clear, especially in high risk patients. Whether strict glyca...

    Authors: Sophie H. Bots, Yolanda van der Graaf, Hendrik M. W. Nathoe, Gert Jan de Borst, Jaap L. Kappelle, Frank L. J. Visseren and Jan Westerink
    Citation: Cardiovascular Diabetology 2016 15:101
    Content type: Original investigation Published on:

  42. Deferred revascularisation based upon fractional flow reserve (FFR >0.80) is associated with a low incidence of target lesion failure (TLF). Whether deferred revascularisation is also as safe in diabetes melli...

    Authors: Mark W. Kennedy, Eliza Kaplan, Rik S. Hermanides, Enrico Fabris, Veemal Hemradj, Petra C. Koopmans, Jan-Hank E. Dambrink, A. T. Marcel Gosselink, Arnoud W. J. van‘t Hof, Jan Paul Ottervanger, Vincent Roolvink, Wouter S. Remkes, Aize van der Sluis, Harry Suryapranata and Elvin Kedhi
    Citation: Cardiovascular Diabetology 2016 15:100
    Content type: Original investigation Published on:

  43. Glucagon-like peptide-1 (7–36) amide (GLP-1) protects against stunning and cumulative left ventricular dysfunction in humans. The mechanism remains uncertain but GLP-1 may act by opening mitochondrial K-ATP ch...

    Authors: Joel P. Giblett, Richard G. Axell, Paul A. White, Sophie J. Clarke, Liam McCormick, Philip A. Read, Johannes Reinhold, Adam J. Brown, Michael O’Sullivan, Nick E. J. West, David P. Dutka and Stephen P. Hoole
    Citation: Cardiovascular Diabetology 2016 15:99
    Content type: Original investigation Published on:

  44. Diabetes mellitus (DM) is associated to the morphological and componential characteristics of atheromatous plaques. It has proven that plaque textures are related to plaque components and beneficial for athero...

    Authors: Xiao-Wei Huang, Yan-Ling Zhang, Long Meng, Ming Qian, Wei Zhou, Rong-Qin Zheng, Hai-Rong Zheng and Li–Li Niu
    Citation: Cardiovascular Diabetology 2016 15:98
    Content type: Original investigation Published on:

  45. Heart failure (HF) and diabetes (DM) are a lethal combination. The current armamentarium of anti-diabetic agents has been shown to be less efficacious and sometimes even harmful in diabetic patients with conco...

    Authors: Jagdeep S. S. Singh, Amir Fathi, Keeran Vickneson, Ify Mordi, Mohapradeep Mohan, J. Graeme Houston, Ewan R. Pearson, Allan D. Struthers and Chim C. Lang
    Citation: Cardiovascular Diabetology 2016 15:97
    Content type: Methodology Published on:

  46. The effects of insulin on cardiomyocytes, such as positive inotropic action and glucose uptake are well described. However, in vitro studies comparing long-acting insulin analogues with regard to cardiomyocyte...

    Authors: Thorsten Hartmann, Sabrina Overhagen, D. Margriet Ouwens, Silja Raschke, Paulus Wohlfart, Norbert Tennagels, Nina Wronkowitz and Jürgen Eckel
    Citation: Cardiovascular Diabetology 2016 15:96
    Content type: Original investigation Published on:

  48. Vascular stiffening, a risk factor for cardiovascular disease, is accelerated, particularly in women with obesity and type 2 diabetes. Preclinical evidence suggests that dipeptidylpeptidase-4 (DPP-4) inhibitor...

    Authors: Camila Manrique, Javad Habibi, Annayya R. Aroor, James R. Sowers, Guanghong Jia, Melvin R. Hayden, Mona Garro, Luis A. Martinez-Lemus, Francisco I. Ramirez-Perez, Thomas Klein, Gerald A. Meininger and Vincent G. DeMarco
    Citation: Cardiovascular Diabetology 2016 15:94
    Content type: Original investigation Published on:

  49. Obesity is associated with multiple adverse cardiovascular conditions and may increase the risk of ventricular tachyarrhythmias (VT/VF). There is limited data on the association between obesity and risk of VT/...

    Authors: Barbara Szepietowska, Bronislava Polonsky, Saadia Sherazi, Yitschak Biton, Valentina Kutyifa, Scott McNitt, Mehmet Aktas, Arthur J. Moss and Wojciech Zareba
    Citation: Cardiovascular Diabetology 2016 15:93
    Content type: Original investigation Published on:

  50. Omentin-1, a novel adipocytokine mainly expressed in visceral adipose tissue, has been found to inhibit the inflammatory response and improve insulin resistance as well as other obesity-related disorders. This...

    Authors: Yu Du, Qingwei Ji, Lun Cai, Fangjiong Huang, Yongqiang Lai, Yue Liu, Jianbo Yu, Bo Han, Enjun Zhu, Jinwei Zhang, Yujie Zhou, Zhijian Wang and Yingxin Zhao
    Citation: Cardiovascular Diabetology 2016 15:90
    Content type: Original investigation Published on:
journal logo

Cardiovascular Diabetology is affiliated with Sackler Faculty of Medicine, Tel-Aviv University

New Content Item

Submit manuscript

Annual Journal Metrics

  • 2022 Citation Impact
    9.3 - 2-year Impact Factor
    9.6 - 5-year Impact Factor
    2.054 - SNIP (Source Normalized Impact per Paper)
    2.361 - SJR (SCImago Journal Rank)

    2023 Speed
    4 days submission to first editorial decision for all manuscripts (Median)
    56 days submission to accept (Median)

    2023 Usage 
    2,523,778 downloads
    3,115 Altmetric mentions 

Cardiovascular Diabetology

ISSN: 1475-2840